Summary
The Eleventh Circuit affirmed Alberico Ahias Crespo’s convictions for conspiracy to commit witness tampering, three counts of witness tampering, and conspiracy to obstruct justice, as well as his 97-month sentence. The court rejected challenges concerning the timeliness of his motion to suppress wiretap evidence, trial evidentiary and mistrial rulings, recross-examination, sufficiency of the evidence, jury instructions, cumulative error, and sentencing calculations.
Topics
Practice areas
Questions Presented
- Whether the district court abused its discretion by denying Crespo's motion to suppress wiretap evidence as untimely and whether the wiretap evidence was nevertheless inadmissible.
- Whether the district court abused its discretion by denying mistrial motions based on false testimony and a prosecutor's allegedly bad-faith question.
- Whether Crespo was entitled to recross-examination after the government's redirect examination of a witness.
- Whether the district court improperly admitted evidence of Crespo's unapproved buying and selling of personal protective equipment under Federal Rule of Evidence 404(b).
- Whether alleged evidentiary and trial errors cumulatively denied Crespo a fair trial.
- Whether sufficient evidence supported the convictions for conspiracy to commit witness tampering, witness tampering, and conspiracy to obstruct justice.
- Whether the district court improperly refused Crespo's proposed good-faith jury instruction.
- Whether the district court correctly calculated Crespo's relevant drug quantity and sentence under the Sentencing Guidelines.
Holdings
- The district court did not abuse its discretion by enforcing the deadline for suppression motions and denying Crespo's motion as untimely. Attorney inadvertence and the government's delayed production of a report did not establish good cause for Crespo's delay.
- The district court did not err in admitting the wiretap evidence, and Crespo failed to establish grounds for a Franks hearing.
- The district court did not abuse its discretion by denying mistrial motions based on an agent's false testimony and a prosecutor's allegedly bad-faith question.
- Crespo had no constitutional right to recross-examination and was not entitled to a limited recross because the government did not introduce a new matter on redirect.
- The district court did not abuse its discretion by admitting evidence that Crespo bought and sold personal protective equipment without HHS approval.
- Crespo was not entitled to reversal under the cumulative-error doctrine because he failed to establish any individual error.
- Sufficient evidence supported Crespo's convictions for conspiracy to commit witness tampering, witness tampering, and conspiracy to obstruct justice.
- The district court did not abuse its discretion by refusing Crespo's proposed good-faith defense instruction.
- The district court correctly calculated Crespo's sentence by attributing to him the relevant oxycodone quantity associated with the portion of the scheme involving Diaz and by applying the accessory-after-the-fact guideline.
Key quotations
“Neither a strategic decision nor inadvertence constitutes good cause.” (18)
“We will reverse the district court’s denial of a mistrial “only if the evidence is so highly prejudicial as to be incurable by the trial court’s admonition.”” (23)
“Rather, he has only a limited right to recross-examination where a new matter is brought out on redirect examination.” (24)
“The cumulative error doctrine provides that an aggregation of non-reversible errors (i.e., plain errors failing to necessitate reversal and harmless errors) can yield a denial of the constitutional right to a fair trial, which calls for reversal.” (29)
Factual background
Crespo was an HHS special agent assigned to a South Florida health-care-fraud task force while sharing a residence with Jorge Diaz Gutierrez, who participated in an oxycodone-trafficking scheme. Crespo knew of Diaz's trafficking and disclosed information about the task force's investigation, including warning Diaz about the investigation and instructing him about what to tell an investigating agent. Crespo also gave investigators false or misleading information concerning patient interviews and attempted to dissuade a participant from speaking with law enforcement. The jury acquitted Crespo of the drug-distribution conspiracy but convicted him of witness-tampering and obstruction-related offenses.
Procedural history
A federal grand jury indicted Crespo and three codefendants on January 5, 2021. After the district court denied Crespo's untimely motion to suppress wiretap evidence, the case proceeded to a thirteen-day trial; the jury acquitted him on the oxycodone-distribution conspiracy count and convicted him on the remaining counts. The district court denied post-trial relief, adopted the Presentence Investigation Report's drug-quantity calculation, and sentenced Crespo to 97 months' imprisonment and three years of supervised release. The Eleventh Circuit affirmed.